RecruitingNCT07379918

Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer

Studying PAPA syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Intervention
Endopredict test(other)
Enrollment
1000 target
Eligibility
18 years · FEMALE
Timeline
20262031

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07379918 on ClinicalTrials.gov

Other trials for PAPA syndrome

Additional recruiting or active studies for the same condition.

See all trials for PAPA syndrome

← Back to all trials